These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12842168)

  • 1. Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study.
    Schüle C; Zwanzger P; Baghai T; Mikhaiel P; Thoma H; Möller HJ; Rupprecht R; Padberg F
    J Psychiatr Res; 2003; 37(2):145-53. PubMed ID: 12842168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
    McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
    Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS.
    Padberg F; Zwanzger P; Thoma H; Kathmann N; Haag C; Greenberg BD; Hampel H; Möller HJ
    Psychiatry Res; 1999 Nov; 88(3):163-71. PubMed ID: 10622338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity.
    Padberg F; Zwanzger P; Keck ME; Kathmann N; Mikhaiel P; Ella R; Rupprecht P; Thoma H; Hampel H; Toschi N; Möller HJ
    Neuropsychopharmacology; 2002 Oct; 27(4):638-45. PubMed ID: 12377400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
    Fava M; Rush AJ; Wisniewski SR; Nierenberg AA; Alpert JE; McGrath PJ; Thase ME; Warden D; Biggs M; Luther JF; Niederehe G; Ritz L; Trivedi MH
    Am J Psychiatry; 2006 Jul; 163(7):1161-72. PubMed ID: 16816220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.
    Oliveira-Maia AJ; Press D; Pascual-Leone A
    Brain Stimul; 2017; 10(4):787-794. PubMed ID: 28438543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive transcranial magnetic stimulation for treatment of medication-resistant depression in older adults: a case series.
    Milev R; Abraham G; Hasey G; Cabaj JL
    J ECT; 2009 Mar; 25(1):44-9. PubMed ID: 18665102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
    Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder.
    Wang YM; Li N; Yang LL; Song M; Shi L; Chen WH; Li SX; Wang XY; Lu L
    Psychiatry Res; 2017 Aug; 254():18-23. PubMed ID: 28441583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.